Skip to content
ClosedNo longer accepting applications

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

DEPT OF DEFENSE

This opportunity closed June 29, 2026. 5 similar opportunities are open right now.

Get alerted when new contract opportunities like this open.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

About this archived opportunity

The Department of Defense (DoD) is required by law (10 U.S.C. � 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following May 2026 newly approved drugs will be reviewed: a. Lifyorli - Oncological Agents - Glucocorticoid Receptor Antagonist b. Quiofic - VITAMINS - WATER SOLUBLE c. Widaplik - ANTIHYPERTENSIVE AGENTS � N/A d. Saphnelo � IMMUNOSUPPRESSIVES � N/A The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9302. Pre-quotation teleconference is on May 13, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.

Historical details

Status
Closed
Deadline
June 29, 2026
First captured
May 8, 2026
Publisher reference
fdb09bd311224930bd4679692488acb0

This opportunity has closed

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

by DEPT OF DEFENSE

Get notified when similar opportunities open

We'll save this search and email you when new pharmacy, uniform, formulary opportunities are posted. Free.

Refine this search